The use of enzymes in industrial
processes is often limited by
the unavailability of biocatalysts with prolonged stability. Thermostable
enzymes allow increased process temperature and thus higher substrate
and product solubility, reuse of expensive biocatalysts, resistance
against organic solvents, and better “evolvability”
of enzymes. In this work, we have used an activity-independent method
for the selection of thermostable variants of any protein in
Thermus thermophilus
through folding interference
at high temperature of a thermostable antibiotic reporter protein
at the C-terminus of a fusion protein. To generate a monomeric folding
reporter, we have increased the thermostability of the moderately
thermostable Hph5 variant of the hygromycin B phosphotransferase from
Escherichia coli
to meet the method requirements.
The final Hph17 variant showed 1.5 °C higher melting temperature
(
T
m
) and 3-fold longer half-life at 65
°C compared to parental Hph5, with no changes in the steady-state
kinetic parameters. Additionally, we demonstrate the validity of the
reporter by stabilizing the 2-keto-3-deoxy-
l
-rhamnonate aldolase
from
E. coli
(YfaU). The most thermostable
multiple-mutated variants thus obtained, YfaU99 and YfaU103, showed
increases of 2 and 2.9 °C in
T
m
compared
to the wild-type enzyme but severely lower retro-aldol activities
(150- and 120-fold, respectively). After segregation of the mutations,
the most thermostable single variant, Q107R, showed a
T
m
8.9 °C higher, a 16-fold improvement in half-life
at 60 °C and higher operational stability than the wild-type,
without substantial modification of the kinetic parameters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.